1532
W.-B. Sun et al.
PAPER
1H NMR (400 MHz, CDCl3): δ = 13.27 (s, 1 H, NH), 7.86 (d, J =
8.0 Hz, 2 H, ArH), 7.67 (d, J = 7.9 Hz, 2 H, ArH), 7.39 (d, J = 8.1
Hz, 2 H, ArH), 6.97 (d, J = 8.1 Hz, 2 H, ArH), 6.71 (s, 1 H, CH),
3.87 (s, 3 H, OCH3), 3.50 (d, J = 11.3 Hz, 6 H, 2 CH3).
13C NMR (75 MHz, CDCl3): δ = 166.26, 161.70, 160.34, 132.62,
132.34, 129.63, 129.14, 125.72, 113.56, 110.74, 55.57, 53.07 (d, JPC
= 5.6 Hz).
HRMS (ESI): m/z [M + H]+ calcd for C14H18N2O5P: 324.0875;
found: 325.0944.
Dimethyl 4-(4-Bromophenyl)-2-methyl-6-oxo-1,6-dihydropy-
rimidin-5-ylphosphonate (5c)
White solid; yield: 0.26 g (70%); mp 212–214 °C.
1H NMR (400 MHz, CDCl3): δ = 13.16 (br s, 1 H), 7.55 (d, J = 8.1
Hz, 2 H), 7.52 (d, J = 8.4 Hz, 2 H), 3.60 (d, J = 11.4 Hz, 6 H), 2.51
(s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 170.9 (d, J = 8.6 Hz), 164.6, 161.7,
138.0, 131.2, 130.8, 124.9, 109.8 (d, J = 200.5 Hz), 53.5 (d, J = 6.0
Hz), 22.0.
HRMS (EI): m/z [M]+ calcd for C20H19BrNO5P: 463.0184; found:
463.0185 (55%).
Dimethyl 4-(2-Methoxyphenyl)-2-oxo-6-phenyl-1,2-dihydro-
pyridin-3-ylphosphonate (3h)
Yellow solid; yield: 0.23 g (60%); mp 168–170 °C.
HRMS (ESI): m/z [M + H]+ calcd for C13H15BrN2O4P: 371.9876;
1H NMR (400 MHz, CDCl3): δ = 13.36 (s, 1 H, NH), 7.95 (d, J =
7.3 Hz, 2 H, ArH), 7.55–7.45 (m, 3 H, ArH), 7.37 (t, J = 7.6 Hz, 1
H, ArH), 7.22 (d, J = 7.1 Hz, 1 H, ArH), 7.02 (t, J = 7.3 Hz, 1 H,
ArH), 6.95 (d, J = 8.2 Hz, 1 H, ArH), 6.59 (s, 1 H, CH), 3.81 (s, 3
H, OCH3), 3.51 (d, J = 11.4 Hz, 3 H, CH3), 3.43 (d, J = 11.3 Hz, 3
H, CH3).
13C NMR (75 MHz, CDCl3): δ = 165.75 (d, JPC = 11.7 Hz), 162.90,
159.21, 156.05, 150.78, 133.18, 130.88, 130.01, 129.36, 127.62,
120.28, 110.63, 55.69, 52.97 (d, JPC = 28.5 Hz).
found: 372.9960.
Dimethyl 4-(4-Chlorophenyl)-2-methyl-6-oxo-1,6-dihydropy-
rimidin-5-ylphosphonate (5d)
White solid; yield: 0.23 g (69%); mp 219–220 °C.
1H NMR (400 MHz, CDCl3): δ = 13.3 (br s, 1 H), 7.59 (d, J = 8.2
Hz, 2 H), 7.38 (d, J = 8.2 Hz, 2 H), 3.60 (d, J = 11.0 Hz, 6 H), 2.49
(s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 171.0 (d, J = 6.1 Hz), 161.5, 137.7,
136.4, 130.6, 128.2, 53.4 (d, J = 4.6 Hz), 22.1.
HRMS (EI): m/z [M]+ calcd for C20H20NO5P: 385.1079; found:
385.1082 (15%).
HRMS (ESI): m/z [M + H]+ calcd for C13H15ClN2O4P: 328.0380;
found: 328.0460.
Dimethyl 6-Methyl-2-oxo-4-phenyl-1,2-dihydropyridin-3-
ylphosphonate (3i)
Dimethyl 6-Oxo-2,4-diphenyl-1,6-dihydropyrimidin-5-ylphos-
phonate (5e)
White solid; yield: 0.27 g (75%); mp 195–197 °C.
1H NMR (400 MHz, CDCl3): δ = 13.6 (br s, 1 H), 8.31–8.55 (m, 2
H), 7.71–7.84 (m, 2 H), 7.35–7.62 (m, 6 H), 3.51 (d, J = 11.1 Hz, 6
Yellow solid; yield: 0.16 g (55%); mp 190–192 °C.
1H NMR (400 MHz, CDCl3): δ = 13.64 (s, 1 H, NH), 7.40 (s, 5 H,
ArH), 6.08 (s, 1 H, CH), 3.53 (d, J = 11.0 Hz, 6 H, 2 CH3), 2.42 (s,
3 H, CH3).
H).
13C NMR (75 MHz, CDCl3): δ = 165.75, 162.78, 149.67, 140.44,
128.63, 128.04, 127.82, 110.47 (d, JPC = 13.5 Hz), 53.00 (d, JPC
5.2 Hz), 19.42.
=
13C NMR (75 MHz, CDCl3): δ = 172.4 (d, J = 8.7 Hz), 158.2, 139.6,
133.2, 131.3, 130.4, 129.6, 129.3, 128.9, 127.9, 53.3 (d, J = 4.6 Hz).
HRMS (EI): m/z [M]+ calcd for C14H16NO4P: 293.0817; found:
HRMS (ESI): m/z [M + H]+ calcd for C18H18N2O4P: 356.0926;
293.0816 (100%).
found: 357.1014.
Dimethyl 2-Methyl-6-oxo-4-phenyl-1,6-dihydropyrimidin-5-
ylphosphonate (5a); Typical Procedure
Dimethyl 6-Oxo-2-phenyl-4-p-tolyl-1,6-dihydropyrimidin-5-
ylphosphonate (5f)
To a mixture of pyrimidinone 4a (0.19 g, 1.0 mmol), dimethyl phos-
phite (0.22 g, 2.0 mmol), and AcOH (5.0 mL) was added
Mn(OAc)3·2 H2O (0.81 g, 3.0 mmol) in 3 portions and the resulting
soln was heated at 80 °C for 2 h. To the resulting mixture was added
H2O (30.0 mL) and it was extracted with EtOAc (3 × 10.0 mL). The
combined organic layers were dried (anhyd Na2SO4) and concen-
trated in vacuo. The residue was purified by column chromatogra-
phy (acetone–petroleum, 2:1) to afford 5a as a white solid; yield:
0.19 g (65%); mp 191–192 °C.
White solid; yield: 0.26 g (70%); mp 189–190 °C.
1H NMR (400 MHz, CDCl3): δ = 13.63 (br s, 1 H), 8.44 (d, J = 7.3
Hz, 2 H), 7.73 (d, J = 7.8 Hz, 2 H), 7.54–7.57 (m, 3 H), 7.27 (d, J =
7.9 Hz, 2 H), 3.55 (d, J = 11.4 Hz, 6 H), 2.42 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 172.6 (d, J = 8.0 Hz), 158.2, 141.1,
136.9, 133.4, 131.6, 131.6, 130.0, 129.5, 129.1, 128.9, 53.5 (d, J =
6.1 Hz), 22.0.
HRMS (ESI): m/z [M + H]+ calcd for C19H20N2O4P: 370.1082;
1H NMR (400 MHz, CDCl3): δ = 13.4 (br s, 1 H), 7.61–7.68 (m, 2
H), 7.41–7.47 (m, 3 H), 3.56 (d, J = 10.1 Hz, 6 H), 2.56 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 172.7 (d, J = 5.0 Hz), 161.7, 139.6,
130.7, 129.5, 128.5, 53.8 (d, J = 2.9 Hz), 22.6.
found: 371.1157.
Dimethyl 4-(3-Methoxyphenyl)-6-oxo-2-phenyl-1,6-dihydropy-
rimidin-5-ylphosphonate (5g)
White solid; yield: 0.25 g (65%); mp 192–193 °C.
HRMS (ESI): m/z [M + H]+ calcd for C13H16N2O4P: 294.0769;
found: 295.0842.
1H NMR (400 MHz, CDCl3): δ = 13.65 (br s, 1 H), 8.44 (d, J = 7.6
Hz, 2 H), 7.54–7.62 (m, 3 H), 7.35–7.41 (m, 3 H), 7.01–7.06 (m, 1
H), 3.88 (s, 3 H), 3.55 (d, J = 11.4 Hz, 6 H).
13C NMR (75 MHz, CDCl3): δ = 172.1 (d, J = 8.6 Hz), 159.2, 140.8,
133.3, 131.8 (d, J = 9.4 Hz), 129.3, 129.2, 129.1, 129.1 (d, J =176.2
Hz), 128.9, 122.0, 116.8, 114.5, 110.0, 55.7, 53.5 (d, J = 6.1 Hz).
Dimethyl 4-(4-Methoxyphenyl)-2-methyl-6-oxo-1,6-dihydropy-
rimidin-5-ylphosphonate (5b)
White solid; yield: 0.22 g (67%); mp 189–191 °C.
1H NMR (400 MHz, CDCl3): δ = 13.30 (br s, 1 H), 7.65 (d, J = 8.6
Hz, 2 H), 6.90 (d, J = 8.6 Hz, 2 H), 3.79 (s, 3 H), 3.55 (d, J = 11.4
Hz, 6 H), 2.47 (s, 3 H).
HRMS (ESI): m/z [M + H]+ calcd for C19H20N2O5P: 386.1032;
found: 387.1103.
13C NMR (75 MHz, CDCl3): δ = 172.1 (d, J = 8.0 Hz), 165.7, 162.0,
161.0, 131.8, 131.7, 113.7, 108.7 (d, J = 201.7 Hz), 55.9, 53.6 (d,
J = 6.1 Hz), 22.4.
Dimethyl 4-(4-Bromophenyl)-6-oxo-2-phenyl-1,6-dihydropy-
rimidin-5-ylphosphonate (5h)
White solid; yield: 0.30 g (68%); mp 240–241 °C.
Synthesis 2013, 45, 1529–1533
© Georg Thieme Verlag Stuttgart · New York